Introduction to Rifampicin Capsules USP 300mg

Rifampicin 300mg Capsules Manufacturers India, Suppliers Rifampicin 300mg Capsules Manufacturer, Supplier in Vapi, Gujarat
Rifampicin 300mg Capsules (Riflitaj 300)

Taj Pharma stands as a leading manufacturer, exporter, and supplier of Rifampicin Capsules USP 300mg in India, catering to both domestic and international markets. With our cutting-edge manufacturing facilities located in Vapi, Gujarat, we uphold the highest standards in pharmaceutical production, backed by WHO-GMP, PICS, and ISO certifications. Taj Pharma is committed to delivering effective, high-quality, and affordable anti-tuberculosis medications to support global health initiatives.

What is Rifampicin 300mg?

Rifampicin Capsules USP 300mg belong to the rifamycin class of antibiotics, playing a crucial role in the treatment of bacterial infections, primarily tuberculosis (TB) and leprosy (Hansen’s disease). Rifampicin works by inhibiting bacterial RNA synthesis, effectively targeting pathogens like:

  • Mycobacterium tuberculosis – the bacterium responsible for TB.
  • Mycobacterium leprae – causing leprosy.
  • Neisseria meningitidis – involved in meningococcal infections.
  • Staphylococcus aureus – including methicillin-sensitive strains (MSSA).

Key Applications of Rifampicin 300mg Capsules

  1. Tuberculosis (TB) Treatment:
    • Rifampicin is a first-line anti-TB drug used in combination therapy for treating both pulmonary and extrapulmonary tuberculosis.
  2. Leprosy (Hansen’s Disease) Management:
    • An essential component of multidrug therapy (MDT), reducing the risk of drug-resistant leprosy.
  3. Meningococcal Prophylaxis:
    • Effective in eliminating Neisseria meningitidis from asymptomatic carriers, reducing meningitis outbreaks.
  4. Severe Staphylococcal Infections:
    • Used to treat methicillin-sensitive Staphylococcus aureus (MSSA) infections, often in combination with other antibiotics.
  5. Brucellosis and Legionnaires’ Disease:
    • Serves as a secondary treatment option for severe bacterial infections.

Rifampicin Capsules USP 300mg – Technical Specifications

Product NameRifampicin Capsules USP
Brand NameGeneric
Strengths Available150mg, 300mg
Dosage FormHard-Gelatin Capsules
Route of AdministrationOral
Packaging Options10s, 30s, 100s, 500s
Regulatory DocumentsCOA, MOA, COPP, FSC, GMP, CTD Dossier
Therapeutic UseAnti-Tuberculosis
Storage Conditions20° to 25°C (68° to 77°F)

Why Choose Taj Pharma for Rifampicin 300mg?

Rifampicin 300mg Capsules Manufacturers India & Pioneer Exporters Rifampicin 300mg Capsules Manufacturers PAN India, Suppliers
Rifampicin 300mg Capsules (Riflitaj 300)

1. Uncompromising Quality Control & Compliance

At Taj Pharma, we adhere to stringent WHO-GMP and PICS guidelines, ensuring that every batch of Rifampicin Capsules USP 300mg meets global quality standards for safety and efficacy. Our advanced quality control processes include:

  • Raw material testing
  • In-process quality checks
  • Finished product analysis
  • Stability testing

2. Advanced Manufacturing Capabilities

Our pharmaceutical plant in Sarigam GIDC, Gujarat boasts high-volume production lines with a capacity to produce:

  • 120 million tablets per month
  • 40 million capsules per month
  • 20 million effervescent tablets per month
  • 3 million oral sachets per month

3. Global Export & Distribution Network

Taj Pharma has established a robust distribution network across India, Africa, the Middle East, Southeast Asia, and Latin America. We actively collaborate with health ministries, hospitals, NGOs, and global distributors to ensure the seamless supply of essential anti-tuberculosis medications.

4. Affordable and Effective Tuberculosis Treatment

Our mission at Taj Pharma is to provide cost-effective TB medications without compromising on quality. We strive to make life-saving antibiotics accessible to populations in high-burden regions.

How to Take Rifampicin 300mg Capsules?

Rifampicin 300mg Capsules Manufacturer Supplier and PCD Pharma Franchise Rifampicin 300mg Capsules – Taj Pharmaceuticals
Rifampicin 300mg Capsules (Riflitaj 300)

Dosage & Administration

  • When to take: 1 hour before or 2 hours after meals (empty stomach).
  • How to take: Swallow the capsule whole with a glass of water — do not chew or crush.
  • Dosage: Follow the prescription strictly as directed by a healthcare provider.

Possible Drug Interactions

  • Oral contraceptives: Rifampicin can reduce their effectiveness.
  • Anticoagulants (Warfarin): May require dosage adjustment.
  • Protease inhibitors (HIV treatment): Interaction may lower their efficacy.
  • Antifungals and immunosuppressants: Potential for drug interactions — consult a physician.

Precautions and Warnings

  • Pregnancy & Lactation: Use only if the benefits outweigh the potential risks — consult your doctor.
  • Liver Function: Regular monitoring is advised for patients with existing liver conditions.
  • Alcohol: Avoid alcohol to prevent liver damage.
  • Drug Resistance: Always use Rifampicin in combination therapy to prevent drug-resistant TB strains.

Storage & Handling Instructions

  • Store at 20°C to 25°C (68°F to 77°F).
  • Keep in a dry place, away from direct sunlight.
  • Ensure it is out of reach of children.

Rifampicin Capsules USP 300mg – Regulatory Approvals & Certifications

Taj Pharma holds multiple certifications, ensuring that all our pharmaceutical products, including Rifampicin 300mg Capsules, meet rigorous global standards. These certifications include:

  • WHO-GMP (World Health Organization – Good Manufacturing Practices)
  • PICS (Pharmaceutical Inspection Co-operation Scheme)
  • ISO 9001:2018
  • EU-GMP (Pending Approval)
  • SGS Audited Manufacturing Facility

Contact Us for Bulk Orders & Pharmaceutical Partnerships

Manufacturing Plant Address: TAJ PHARMA INDIA LTD.
Plot No. 1019, Vill. – Sarigam,
G.I.D.C., Road No. 10, Dist. – Valsad,
Gujarat, India – 396155.
Tel: +91 – 22 – 2637 4592
Email: info@tajpharma.com

For inquiries regarding bulk orders, contract manufacturing, or distribution partnerships, contact us today.